COMP <GO>
BON vs MRK // GROSS PROFIT MARGIN
Bon Natural Life Limited (Class A) (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: BON 0
— MRK 9
▲ GROSS PROFIT MARGIN LEADER: MRK
LAST: $1.14 (+0.89%) • MKT CAP: $9.2M
gross-margins
20.80%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
gross-margins
74.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BON VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BON | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 20.80% | 74.80% | -54.00 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 20.70% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.46% | 3.42% | -1.96 | MRK | /fcf-yield <GO> |
| Operating Margin | -8.70% | 34.30% | -43.00 | MRK | /operating-margins <GO> |
| Net Profit Margin | -10.70% | 28.10% | -38.80 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -21.70% | 1.30% | -23.00 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.19 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.5 | 51.7 | -6.20 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.2M | $361.02B | -$361.01B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BON REV | MRK REV | BON GROSS % | MRK GROSS % | BON FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.7M | $65.01B | 20.8% | 74.8% | $134.3K | $12.36B |
| FY 2024 | $23.8M | $64.17B | 29.8% | 76.3% | -$7.7M | $18.10B |
| FY 2023 | $29.5M | $60.12B | — | — | -$616.9K | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BON // BETA —
MRK // BETA 0.92